UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

(Amendment No.1)

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 23, 2020

 

GENUFOOD ENERGY ENZYMES CORP.

(Exact name of registrant as specified in charter)

 

Nevada   000-56112   68-0681158
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

601 South Figueroa Street, Suite 4050

Los Angeles, California

  90017
(Address of principal executive offices)   (Zip Code)

                                                                              

(213) 330-6770

Registrant’s telephone number

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

 

Item 3.03. Material Modification to Rights of Security Holders.

 

As previously reported, on June 23, 2020, the Board of Directors of Genufood Energy Enzymes Corp., a Nevada corporation (the “Company”), approved a reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-100.

 

The Reverse Stock Split became effective with the Secretary of State of the State of Nevada at 9:00 a.m. on July 6, 2020, and with the Financial Industry Regulatory Authority (FINRA) and in the marketplace upon the opening of the OTC Markets on July 23, 2020 (the “Effective Date”). On the Effective Date, the shares of the Company’s Common Stock began trading on a split-adjusted basis. On the Effective Date, the Company’s trading symbol changed to “GFOOD” and will remain as such for a period of 20 trading days, after which the “D” will be removed from the Company’s trading symbol and it will revert to the original symbol of “GFOO”. In connection with the Reverse Stock Split, the Company’s CUSIP number changed to 37252L209 with respect to all shares of stock traded or issued on or after the Effective Date.

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GENUFOOD ENERGY ENZYMES CORP.  
       
Date:  July 23, 2020 By: /s/ Jui Pin Lin  
   

Jui Pin Lin

Chief Executive Officer

 


 

-3-